
Innovating for Successful Human Peripheral Blood Mononuclear Cell Isolation in Patients’ Own Homes
Posted | March 8, 2023The Challenge mdgroup recently supported a single ascending dose hybrid clinical trial, which investigated ways to correct the problem in protein transcription in the gene overexpression of Friedrich's Ataxia, an…